Pay in 4 interest-free payments of $6.02 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
It's not approved by the FDA as a drug or dietary supplement and is considered a research compound
Brahimaj A, Muka T, Kavousi M, Laven JS, Dehghan A, Franco OH
The standardized spray formulation enables researchers to investigate intranasal peptide delivery, formulation science, and analytical performance while maintaining rigorous quality standards for Research Use Only applications
In rodent models, high-dose Cerebrolysin (above 10ml/kg IV) can cause transient agitation or hyperactivity within 30 minutes post-injection, resolving within 24 hours
Secondary outcome measurements included reduction in body weight from baseline by at least 5% or 10% by week 26, changes in waist circumference, total cholesterol, HDL, LDL, VLDL, and triglycerides, and levels of different glycemic variables including HbA1C, fasting plasma glucose, fasting insulin, insulin resistance, and the functioning of beta-cells
Preclinical Toxicology: Toxicity studies in rodents indicate that even high doses (e.g., 20 mg/kg) do not result in gross organ toxicity or lethality in the acute setting
US$ 29.96
US$ 20.12
US$ 26.12
US$ 24.85
US$ 27.07
